# The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy

> **NCT02024191** · PHASE3 · UNKNOWN · sponsor: **Ankara Education and Research Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Peripheral Neuropathy

## Interventions

- **DIETARY_SUPPLEMENT:** Glutamine

## Key facts

- **NCT ID:** NCT02024191
- **Lead sponsor:** Ankara Education and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2015-01
- **Final completion:** 2015-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2013-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02024191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02024191, "The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02024191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*